- Previous Close
0.0100 - Open
0.0100 - Bid 0.0050 x --
- Ask 0.0100 x --
- Day's Range
0.0100 - 0.0100 - 52 Week Range
0.0050 - 0.0150 - Volume
11,400 - Avg. Volume
1,413,449 - Market Cap (intraday)
51.091M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 26, 2013
- 1y Target Est
--
Hong Seng Consolidated Berhad, an investment holding company, engages in gloves and NBL manufacturing, healthcare, and financial services in Malaysia and Australia. It operates through Healthcare, Financial Services, and gloves, search and advertising, and other segments. The company offers medical diagnostic and research laboratory services; wholesale of pharmaceutical and medical products; and money lending services. It also develops and provides online presence and advertising solutions; operates search platforms; publishes business directory journals; provides content development and database marketing services. In addition, the company manufactures and trades in rubber gloves, and offers genetic research and testing services. Further, it is involved in the construction and operation of tank farm facilities for feedstocks storage and related integrated logistics services; manufacture and trade of nitrile butadiene latex and other related business; and property investment business. The company was formerly known as MSCM Holdings Berhad and changed its name to Hong Seng Consolidated Berhad in October 2020. Hong Seng Consolidated Berhad was incorporated in 2001 and is based in Petaling Jaya, Malaysia
www.hongseng.com.myRecent News: 0041.KL
View MorePerformance Overview: 0041.KL
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0041.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0041.KL
View MoreValuation Measures
Market Cap
51.09M
Enterprise Value
49.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.31
Price/Book (mrq)
0.17
Enterprise Value/Revenue
5.62
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
24.24%
Return on Assets (ttm)
15.50%
Return on Equity (ttm)
38.50%
Revenue (ttm)
228.69M
Net Income Avi to Common (ttm)
55.43M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
152.62M
Total Debt/Equity (mrq)
5.50%
Levered Free Cash Flow (ttm)
-103.07M